Recent News

By Category: Bioterrorism

Ricin Letter Adds To Anxiety on the Hill

(GlobalSecurityNewswire) Amid an already edgy state of alert in Washington following Monday’s bombings at the Boston Marathon, law enforcement officials confirmed on Tuesday that they were also investigating whether an envelope containing the poison ricin was intended to harm Senator Roger Wicker (R-Miss.). “The U.S. Capitol Police, the FBI and other agencies are involved in Read More »

April 17, 2013
| Filed under North America and Bioterrorism
Share

US Army awards Gainesville firm $136M contract to fight bioterrorism

(BusinessJournal) The U.S. Army has awarded a Gainesville-area company a contract to make and develop treatments for bioterrorism and radiological threats to military personnel, according to a government contracts website. The company, Nanotherapeutics, plans to build a $150 million, 145,000-square-foot expansion and add as many as 150 new employees with an average salary of $90,000 Read More »

April 16, 2013
| Filed under North America, Bioterrorism, and Policy & Initiatives
Share

House re-ups bioterrorism, public health funding

(Government Health IT) In late January, the House passed a bill funding several public health preparedness and monitoring programs, including bioterrorism surveillance and the federal disaster medical system, getting support from the biotechnology and public health communities, in the wake of Hurricane Sandy. The Pandemic and All-Hazards Preparedness Reauthorization Act (HR 307) passed by a Read More »

January 30, 2013
| Filed under North America, Agents & Toxins, Bioterrorism, and Policy & Initiatives
Share

Bomb and anthrax hoax at Camden building

(Philadelphia Inquirer) The FBI is investigating a bomb and anthrax hoax at the U.S. District Court building in Camden. A mail clerk opened an envelope Friday morning to find a letter claiming a bomb was in the building and the white powder inside the envelope was anthrax, said Juan Matos, the U.S. marshal for New Read More »

January 14, 2013
| Filed under North America, Agents & Toxins, and Bioterrorism
Share

FDA Offers First License to Drug Produced by Bioshield Program

(Global Security Newswire) The U.S. Food and Drug Administration on Friday issued a license for a new anthrax treatment, marking the first time the agency has approved a drug developed through the federal government’s controversial Project Bioshield program. The U.S. Health and Human Services Department has since 2005 acquired an unspecified amount of Raxibacumab through Read More »